Takashi Yamanaka

Takashi Yamanaka

Auto-generated profile, based on publicly available information

Takashi Yamanaka

Department of Home Care Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Equine Science
Verified
Journal Article
Open access
MMMasanori Muranaka
Masanori Muranaka
TYTakashi Yamanaka
Takashi Yamanaka
YKYoshinari Katayama
Yoshinari Katayama
HNHidekazu Niwa
Hidekazu Niwa
KOKazuomi Oku
Kazuomi Oku
TOToshifumi Oyamada
Toshifumi Oyamada
To investigate the pathology of equine influenza, necropsy of 7 horses experimentally infected with equine influenza A virus (EIV) subtype H3N8 was conducted on post-infection days (PID) 2, 3, 7, and 14. Histopathologically, rhinitis or tracheitis including epithelial degeneration or necrosis with loss of ciliated epithelia and a reduction in goblet cell numbers, was observed in the respiratory tracts on PIDs 2 and 3. Epithelial hyperplasia or squamous metaplasia and suppurative bronchopneumonia with proliferation of type II pneumocytes were observed on PIDs 7 and 14. Viral antigen was detected immunohistochemically in the epithelia of the nasal mucosa, trachea, and bronchi on PIDs 2 and 3. The sodA gene of Streptococcus equi subsp. zooepidemicus, a suspected cause of suppurative bronchopneumonia, was detected in paraffin-embedded lung tissue sections, but only on PIDs 7 and 14. These findings suggest that damage caused to ciliated epithelia and goblet cells by EIV infection results in secondary bacterial bronchopneumonia due to a reduction in mucociliary clearance.

1 January 2005 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
SMShougo Murakami
Shougo Murakami
KOKuniaki Otsuka
Kuniaki Otsuka
YKYutaka Kubo
Yutaka Kubo
MSMakoto Shinagawa
Makoto Shinagawa
OMOsamu Matsuoka
Osamu Matsuoka
YKYasushi Kitaura
Yasushi Kitaura
Although blood pressure (BP) is a major determinant of pulse wave velocity (PWV), some treatments have independent effects on BP and arterial stiffness. Although both ambulatory BP (ABP) and self-measured BP at home (HBP) have become important measures for the diagnosis and management of hypertension, single day recordings may be insufficient for a proper diagnosis of hypertension or the evaluation of treatment efficacy. To evaluate weekly variations in BP using 7-day HBP and 7-day ABP monitoring and to determine the relation between arterial stiffness and BP measurements in community-dwelling patients with hypertension. We enrolled 68 community-dwelling hypertensive subjects in this study. Significant weekly variations in systolic blood pressure (SBP) and diastolic blood pressure (DBP) were found in the awake ABP data (p < .01, respectively), while no significant weekly variations in the asleep ABP or the morning and evening HBP data were observed. In untreated subjects, significant correlations were obtained between the brachial-ankle PWV and the average awake SBP, the average asleep SBP and the average SBP measured by HBP in the evening. In treated subjects, only the average SBP measured by HBP in the morning was significantly correlated with the baPWV. Differences in the weekly variations in BP were observed between HBP and ABP monitoring. In addition, the morning systolic HBP was not correlated with arterial stiffness in untreated subjects with hypertension but was correlated in treated subjects. Relations between the morning HBP and arterial stiffness might be attributed to morning surges in BP and/or trough levels of antihypertensive drugs.

YYYasuhiro Yamaguchi
Yasuhiro Yamaguchi
KSKM Saif-Ur-Rahman
KM Saif-Ur-Rahman
MNMotoko Nomura
Motoko Nomura
HOHiromitsu Ohta
Hiromitsu Ohta
YHYoshihisa Hirakawa
Yoshihisa Hirakawa
HMHisayuki Miura
Hisayuki Miura
A previous pooled analysis demonstrated significant relief of breathlessness following opioid administration in patients with chronic obstructive pulmonary disease. However, in clinical practice, it is important to know the characteristics of patients responding to opioids, the best prescription methods, and the evaluation measures that can sufficiently reflect these effects. Thus, we performed a systematic review of systemic opioids for non-cancer chronic respiratory diseases. Fifteen randomized controlled studies (RCTs), four non-randomized studies, two observational studies, and five retrospective studies were included. Recent RCTs suggested that regular oral opioid use would decrease the worst breathlessness in patients with a modified Medical Research Council score ≥ 3 by a degree of 1.0 or less on a scale of 1–10. Ergometer or treadmill tests indicated mostly consistent significant acute effects of morphine or codeine. In two non-randomized studies, about 60% of patients responded to opioids and showed definite improvement in symptoms and quality of life. Furthermore, titration of opioids in these studies suggested that a major proportion of these responders had benefits after administration of approximately 10 mg/day of morphine. However, more studies are needed to clarify the prescription method to reduce withdrawal due to adverse effects, which would lead to significant improvements in overall well-being.

10 December 2019 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
KKKiwami Kidana
Kiwami Kidana
SIShinya Ishii
Shinya Ishii
IOItsuki Osawa
Itsuki Osawa
AYAyu Yoneda
Ayu Yoneda
KYKiyoshi Yamaguchi
Kiyoshi Yamaguchi
TYTakashi Yamanaka
Takashi Yamanaka

1 January 2007 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
TYTakashi Yamanaka
Takashi Yamanaka
MYMasayuki Yamada
Masayuki Yamada
KTKoji Tsujimura
Koji Tsujimura
TKTakashi Kondo
Takashi Kondo
SNShunichi Nagata
Shunichi Nagata
TMTomio Matsumura
Tomio Matsumura
The aim of this study was to investigate the pharmacokinetics of oseltamivir carboxylate (OC) in horses (n=6) after oral administration of its prodrug oseltamivir. The binding rate of OC to horse plasma proteins was negligible (<1%). Oral administration of oseltamivir of 2 mg/kg body weight of oseltamivir to horses provided a plasma concentration of OC (mean maximum concentration: 257.9 ng/ml) above the inhibitory concentrations against equine influenza A viruses determined in vitro. However, because OC is rapidly eliminated from horse plasma (mean elimination half-life: 2.5 hr), administration intervals should be less than 10 hr to retain a suitable concentration when using a single dose of 2 mg/kg oseltamivir.

6 April 2018 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
TYTakashi Yamanaka
Takashi Yamanaka
YHYoshito Hirota
Yoshito Hirota
MNMaiko Noguchi-Watanabe
Maiko Noguchi-Watanabe
ATAnna Tamai
Anna Tamai
MEMasato Eto
Masato Eto
MAMasahiro Akishita
Masahiro Akishita